Keros Therapeutics (KROS) Net Cash Flow (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,567.21% |
| Sep 30, 2025 | 110.74% |
| Jun 30, 2025 | -118.88% |
| Mar 31, 2025 | 449.15% |
| Dec 31, 2024 | -76.61% |
| Sep 30, 2024 | 441.88% |
| Jun 30, 2024 | -132.87% |
| Mar 31, 2024 | 157.31% |
| Dec 31, 2023 | 226.30% |
| Sep 30, 2023 | -16.48% |
| Jun 30, 2023 | -140.62% |
| Mar 31, 2023 | 82.68% |
| Dec 31, 2022 | 66.44% |
| Sep 30, 2022 | 283.61% |
| Jun 30, 2022 | -790.45% |
| Mar 31, 2022 | -116.75% |
| Dec 31, 2021 | 159.73% |
| Sep 30, 2021 | 19.56% |
| Jun 30, 2021 | -69.49% |
| Mar 31, 2021 | -108.08% |
| Dec 31, 2020 | 1,314.18% |
| Sep 30, 2020 | -112.06% |
| Jun 30, 2020 | 89.84% |
| Mar 31, 2020 | 961.72% |
| Dec 31, 2019 | -81.85% |
| Sep 30, 2019 | 41.70% |
| Jun 30, 2019 | -106.88% |